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Abstract: Increased oxidative stress is an unavoidable consequence of exposure to the space
environment. Our previous studies showed that mice exposed to space for 13.5 days had
decreased glutathione levels, suggesting impairments in oxidative defense. Here we performed
unbiased, unsupervised and integrated multi-‘omic analyses of metabolomic and transcriptomic
datasets from mice flown aboard the Space Shuttle Atlantis. Enrichment analyses of metabolite
and gene sets showed significant changes in osmolyte concentrations and pathways related to
glycerophospholipid and sphingolipid metabolism, likely consequences of relative dehydration of the
spaceflight mice. However, we also found increased enrichment of aminoacyl-tRNA biosynthesis and
purine metabolic pathways, concomitant with enrichment of genes associated with autophagy
and the ubiquitin-proteasome. When taken together with a downregulation in nuclear factor
(erythroid-derived 2)-like 2-mediated signaling, our analyses suggest that decreased hepatic oxidative
defense may lead to aberrant tRNA post-translational processing, induction of degradation programs
and senescence-associated mitochondrial dysfunction in response to the spaceflight environment.
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1. Introduction
Long-duration spaceflight is associated with significant risks including prolonged exposure
to microgravity, continuous exposure to low-dose/low-dose rate radiation, psychological and
environmental stress and contact with potentially dangerous levels of microbial contamination [1–5].
Radiation is known to induce single (SSB) and double strand (DSB) DNA breaks, permanently
damaging nuclear and mitochondrial DNA and leading to early apoptosis or necrosis [6–8].
At low-dose/low-dose rates, radiation immediately triggers oxidative stress via a spike in the level of
reactive oxygen species (ROS). Acute psychological stress increases hepatic lipid peroxidation as well
as levels of ROS [9], however chronically stressed animals compensate [9,10]. Therefore, exposure to
the space environment, characterized by changes in physiological and psychological stress, as well
as exposure to low-dose/low-dose rate radiation, may systemically alter ROS levels in a complex
fashion [11–13].
Excessive ROS production, without a corresponding upregulation in antioxidant or ROS scavenger
pathways, can cause damage to cellular components including DNA, proteins and lipids, inducing
pro-inflammatory cytokines and the nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB)
pathway [14]. This can lead to cell cycle arrest, activation of senescence or apoptosis and upregulation
of inflammatory signaling molecules, causing widespread organelle, cell and tissue damage [15].
Under conditions of chronic exposure to oxidative stress (such as in spaceflight), an imbalance
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occurs between ROS production and antioxidant quenching resulting in increased cellular and
tissue damage [16–18]. Mitochondria are particularly vulnerable to damage by excess ROS and we
hypothesized that the liver, a mitochondria-rich metabolic organ, may be a target of spaceflight-induced
deficits. In support of this hypothesis, astronauts were shown to exhibit a mild diabetogenic phenotype
following spaceflight, the severity of which was linked with flight duration [19,20].
We previously demonstrated that mice flown aboard the Space Shuttle Atlantis (Space
Transportation System (STS)-135) for 13.5 days exhibited a significantly impaired response to
oxidative stress evidenced by decreased hepatic levels of the antioxidant glutathione (GSH, reduced),
with concomitant increased ophthalmate, a biomarker for depletion of glutathione, and increased
ratio of glutathione disulfide (GSSG):GSH [21]. Other spaceflight-induced changes in hepatic genes
linked to oxidative defense have also been observed [13]. Our targeted analyses of metabolomics and
transcriptomics datasets obtained from livers of spaceflight mice showed dysregulation of pathways
involved in both lipid metabolism and the immune response, with signs of retinoid export and
activation of peroxisome proliferator-activated receptor (PPAR) pathways suggestive of nascent hepatic
fat accretion and collagen deposition. Proteomics data acquired from mice exposed to space for 30 days
exhibited similar patterns when compared with mice re-acclimated to ground conditions [22].
Our previous integrated data analysis utilized a limited set of genes and metabolites that were
elevated in abundance in spaceflight mice as compared with ground controls and were tightly
correlated with histological evidence of increased hepatic lipid accumulation. The goal of the present
study was to perform unbiased, integrated analyses using the entire metabolomics and transcriptomics
datasets to determine whether additional insights into the effects of exposure to the space environment
on liver metabolism and cellular function could be gleaned. Utilizing several enrichment algorithms,
we determined that degradation and senescence programs were altered in spaceflight mice in concert
with attenuation of oxidative defense networks.
2. Results and Discussion
2.1. Short Duration Exposure to the Space Environment Significantly Alters Hepatic Metabolite Profiles
Previously, we selected specific genes and metabolites to interrogate from our large-scale-‘omics
datasets to address defined hypotheses. Here, we performed unsupervised Partial Least Squares
Discriminant Analysis (PLS-DA) using the entire metabolomics dataset to determine whether 13.5 days
of exposure to the space environment was sufficient to induce significant changes in metabolism in
livers of mice flown in space (FLT) as compared with matched ground controls (AEM). The scores
plot of the PLS-DA analysis demonstrates clear separation between the FLT mice (green) and AEM
controls (red) (Figure 1A). Volcano plot analysis (Figure 1B) shows that 10 biochemicals increased
in FLT mice with a fold change (FC) greater than 2 and a p (corr)-value less than 0.05, while only
3 biochemicals decreased in the FLT mice as compared to the AEM controls (Table 1) from a total of
14 upregulated (FC > 2) and 11 downregulated (FC < 0.5) biochemicals (Figure S1A and Table S1).
Variable Influence on Projection (VIP) analysis of the top 15 most important features contributing to
the clustering is plotted in Figure S1B and the most significant features in the volcano plot also appear
within the top 15 VIP features. Hierarchical clustering with organization of features by VIP score
(Figure 1C) also shows clear separation of metabolite features between the two groups, with relatively
fewer metabolites decreased in abundance in the FLT mice as compared with the AEM controls.
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Figure 1. Brief exposure to the space environment results in significant metabolite changes in mouse 
liver. (A) PLS-DA analysis was performed on normalized metabolomics data that was subsequently 
log-transformed and auto-scaled. The first two components are plotted; (B) volcano plot comparing 
flown in space (FLT) vs. matched ground controls (AEM) considering unequal variance and using a 
fold change (FC) threshold of 2 and a p (corr)-value threshold of 0.05. Data points in red indicate 
significant named biochemical features. Data points in blue are not significant; (C) heat map and 
hierarchical clustering performed using a Pearson score for the distance measure, with features 
organized by VIP score from the PLS-DA analysis. Red—AEM, green—FLT; red indicates compounds 
with high signal abundance and blue those with low signal abundance. Color intensity correlates with 
relative signal abundance. n = 6/group. 
Table 1. Significantly changing biochemicals in spaceflight identified in volcano plot analysis. 
Biochemicals FC log2 (FC) p −log10 (p) 
Reduced     
4-Guanidinobutanoate 1,* 0.377 −1.409 1.98 × 10−5 4.703 
Glycerophosphorylcholine * 0.282 −1.826 1.52 × 10−3 2.817 
3-Ureidopropionate 0.466 −1.102 3.83 × 10−2 1.417 
Increased     
3-hydroxybutyrate * 3.229 1.691 7.54 × 10−5 4.123 
Glutarate pentanedioate * 4.766 2.253 8.40 × 10−5 4.076 
Propionylcarnitine * 2.440 1.287 1.68 × 10−4 3.776 
3-methylglutarylcarnitine * 3.478 1.798 5.90 × 10−4 3.229 
Dimethylglycine * 2.195 1.134 1.87 × 10−3 2.728 
Hexadecanedioate * 2.189 1.131 2.07 × 10−3 2.684 
Figure 1. Brief exposure to the space environment results in significant metabolite changes in mouse
liver. (A) PLS-DA analysis was performed on normalized metabolomics data that was subsequently
log-transformed and auto-scaled. The first two components are plotted; (B) volcano plot comparing
flown in space (FLT) vs. matched ground controls (AEM) considering unequal variance and using a fold
change (FC) threshold of 2 and a p (corr)-value threshold of 0.05. Data points in red indicate significant
named biochemical features. Data points in blue are not significant; (C) heat map and hierarchical
clustering performed using a Pearson score for the distance measure, with features organized by VIP
score from the PLS-DA analysis. Red—AEM, green—FLT; red indicates compounds with high signal
abundance and blue those with low signal abundance. Color intensity correlates with relative signal
abundance. n = 6/group.
Table 1. Significantly changing biochemicals in spaceflight identified in volcano plot analysis.
Biochemicals FC log2 (FC) p −log10 (p)
Reduced
4-Guanidinobutanoate 1,* 0.377 −1.409 1.98 × 10−5 4.703
Glycerophosphorylcholine * 0.282 −1.826 1.52 × 10−3 2.817
3-Ureidopropionate 0.466 −1.102 3.83 × 10−2 1.417
Increased
3-hydroxybutyrate * 3.229 1.691 7.54 × 10−5 .123
Glutarate pentaned oate * 4.766 2.253 8.40 × 10−5 4.0
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Table 1. Cont.
Biochemicals FC log2 (FC) p −log10 (p)
Propionylcarnitine * 2.440 1.287 1.68 × 10−4 3.776
3-methylglutarylcarnitine * 3.478 1.798 5.90 × 10−4 3.229
Dimethylglycine * 2.195 1.134 1.87 × 10−3 2.728
Hexadecanedioate * 2.189 1.131 2.07 × 10−3 2.684
Ophthalmate 2.326 1.218 1.30 × 10−2 1.887
Hydroxyisovaleroyl carnitine 2.567 1.360 1.37 × 10−2 1.862
Putrescine 2.857 1.514 3.48 × 10−2 1.459
Cholate 2.602 1.380 4.98 × 10−2 1.302
Taurodeoxycholate 2.978 1.574 5.00 × 10−2 1.301
1, biochemical with the most significant change in volcano plot and FC analysis. *, indicates biochemical is also one
of the top 15 VIP features contributing to the PLS-DA analysis. FC–fold change comparing FLT to AEM controls.
n = 6/group.
2.2. Altered Betaine and Glutathione Metabolism Are Central Defects in Spaceflight Mouse Livers
Metabolite set enrichment was performed in MetaboAnalyst using pathway-associated metabolite
sets based on “normal metabolic pathways” (Figure 2). Enrichment was performed using either all
metabolites (Figure 2A) or a more limited subset consisting only of those significantly changing in
abundance (Figure 2B). Significance was determined by two-tailed Student’s t-test. A fold-change
cutoff was not applied, therefore some of the significant metabolites differ from those identified
in the volcano plot. When enrichment analysis was performed using all metabolites, relatively
few p (corr)-values for enriched metabolite sets reached significance (p < 0.05). However, the top
several sets (methionine metabolism, branched chain fatty acid oxidation, betaine metabolism and glycine,
serine and threonine metabolism) were retained when the limited subset of metabolites was used for
analysis (Figure 2B). Furthermore, enrichment of glutathione and glutamate metabolism, important
components of the response to oxidative stress, rose to significance in the analysis of the limited
dataset, suggesting the utility of performing the same analysis multiple times on different subsets of
the data.
We next identified specific metabolites that were contributing to the enrichment scores. The glycine,
serine and threonine metabolism enrichment score was based on decrease of cystathionine and increase of
betaine and dimethylglycine. Eight other metabolites contributed to the enrichment, however their
abundance changes were not significant between groups. The glutathione metabolism enrichment score
was based on decreased abundance of glutathione and cysteinylglycine in FLT mice as compared
with AEM controls, with additional contributions from four non-significantly changing metabolites.
Fatty acid oxidation enrichment scores (both branched chain and very long chain) were based on abundance
of propionylcarnitine and carnitine, with coenzyme A and acetyl carnitine contributing to the score
as well. It should be noted that MetaboAnalyst does not recognize many lipids, therefore lipid
metabolic pathways are likely under-represented. Contributors to enrichment of methionine metabolism
were similar to those of betaine metabolism and consisted primarily of betaine, dimethylglycine and
choline, with additional contributions from S-adenosylhomocysteine and 5-methyltetrahydrofolic
acid, suggesting activation of the S-adenosyl methionine (SAM) cycle in the FLT mice. Abundances of
these metabolites in FLT mouse livers and AEM controls are summarized in Table S2. For validation,
metabolite pathway analysis was performed and similar pathways were found to have a high impact
score based on enrichment and topology analysis (Figure S2).
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Figure 2. Metabolite set enrichment analysis reveals metabolic pathways enriched in livers of FLT 
mice. Enrichment analysis was performed in MetaboAnalyst using (A) all metabolites or (B) only 
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Figure 2. etabolite set enrichment analysis reveals metabolic pathways enriched in livers of FLT mice.
Enrichment analysis was performed in MetaboAnalyst using (A) all metabolites or (B) only metabolites
with significantly changing abundances between groups (p < 0.05). n = 5/group. Eighty-eight
metabolite sets based on “normal etabolic pathways” were used for the analysis. For clarity of
presentation, only the ost significantly enriched etabolite sets are annotated.
We previously reported a significant increase in abundance of betaine in FLT livers [4,5]. Betaine is
metabolized from choline, which decreased in FLT mice [4,5]. Betaine is also a methyl donor and
provides the methyl group for metabolism of homocysteine to methionine, generating dimethylglycine
as well. Furthermore, the transmethylation cycle provides substrates used for the synthesis of
cystathionine and GSH via transsulferation [23]; labile methyl groups are required for these processes
as well as support of folate metabolism and synthesis of methylated compounds. Since methionine
is lost in the transmethylation pathway, it is possible that choline is supplied to preserve pathway
function [24]. However, the observed increase in abundance of betaine with a concomitant decrease in
cystathionine and GSH suggests increased choline metabolism in spaceflight is not linked to augmented
activation of one carbon metabolic pathways, since abundance levels of relevant metabolites such as
S-adenosylhomocysteine, serine, sarcosine and glycine are unchanged. Therefore, other mechanisms
are likely involved.
Dietary choline and methionine induce lipotrophic effects through upregulation of very
low-density lipoprotein export and fatty acid oxidation, and choline deficiency has been associated
with oxidative stress, inflammation, and steatosis. Shown in Figure 3, histological assessment confirms
that spaceflight indeed results in increased presence of inflammatory cells as well as augmented
steatosis. Although we previously measured upregulation of mRNA expression levels of PPAR-α,
a transcriptional regulator of fatty acid oxidation, it is likely that PPAR activation is mediated through
increased retinol abundance instead of elevated choline [5]. Choline may be replenished by recycling
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from phosphatidylcholine, which may impair integrity of lipid membranes. Metabolomics analysis
of choline-containing lysolipids revealed an average 40% decrease in abundance of these lipids in
FLT mice as compared to AEM controls, although differences between groups were not significant for
individual features (Figure S3). These results suggest that augmented metabolism of betaine, in excess
of what is needed for methionine metabolism, may lead to injurious choline deficits in spaceflight mice.
Whether this is causally related to decreased glutathione and the ability to respond to oxidative stress
remains an open question.Int. J. Mol. Sci. 2017, 18, 2062 6 of 22 
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Table 2. Average food and water intake measurements for STS-135 mice and AEM controls. 
Intake AEM a FLT FLT/AEM p-Value 
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Water Intake (g) 3.38 ± 0.22 2.73 ± 0.01 0.81 0.038 
a, Food and water consumption were measured over the 13.5-day flight. Values represent mean ± 
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Figure 3. Increased steatosis and infiltration of inflammatory cells in livers from mice exposed to
spaceflight. H&E staining was performed on fixed liver sections from n = 4–5 mice/group to investigate
liver histology. Inspection of the H&E stained sections revealed that the AEM ground control mice
had small cytoplasmic lipid droplets predominantly located in zone 2 whereas the FLT mice had an
increase in slightly larger droplets distributed in a panlobular pattern. Multiple lipid droplets are
indicated using white arrows. Furthermore, FLT mice showed increased accumulation of mononuclear
inflammatory cells, particularly near portal ducts (yellow arrow). Representative images are shown
from each group. PT = portal triad, CV = central vein. Scale bar = 100 µm.
Notably, betaine serves as an organic osmolyte, protecting cells from effects of dehydration.
Water intake in FLT mice was decreased by ~20% as compared to AEM controls, although food
intake was unchanged (Table 2), therefore a likely cause for the upregulation of betaine is dehydration.
We also measured upregulation of taurine, another osmolyte. Abundance of 4-guanidinobutanoate was
strikingly decreased (Figure S1A) and was the most important feature contributing to the clustering of
groups in the PLS-DA analysis (Figure S1B). Guanidino compounds are metabolized from arginine,
and dehydration modifies abundance of these compounds in the kidney [25]. Kidney injury not
only results in red ced arginine synthesis but change in l vels of guanidino compounds and their
metabolism in muscles and liver [26]. The marked decrease in abundanc of 4-guanidinobutanoate
may therefore be associated with dehydration in the FLT mice. Ma y of the most str king changes in
metabolite and transcript abunda ces appeared to be related to increased dehydration of the FLT mice
as compared to AEM cont ols; although this is a possible limitation f the study, a ecent proteomics
study on livers from male mice in the “Bion-M1” study flown in space for 30 days and re-acclimated
showed results similar to those from our previously published data [22]. Therefore, either the Bion-M1
mice were also dehydrated, or the enriched pathways that we measured indeed have functional
significance, potentially related to a shift in metabolic requirements due to unloading. Taken together,
the data suggest that dehydration, coupled with oxidative stress, combine to deplete choline stores,
leading to impaired lipid membrane metabolism and contributing to increased steatosis in livers from
mice exposed to spaceflight.
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Table 2. Average food and water intake measurements for STS-135 mice and AEM controls.
Intake AEM a FLT FLT/AEM p-Value
Food Intake (g) b 4.08 ± 0.10 4.09 ± 0.18 1.00 0.865
Water Intake (g) 3.38 ± 0.22 2.73 ± 0.01 0.81 0.038
a, Food and water consumption were measured over the 13.5-day flight. Values represent mean ± SEM;
b, Intake values are means calculated for 3 cages of 5 mice per group. Table adapted from [5].
2.3. Spaceflight Causes Broad Alterations in Transcriptome Profiles in the Liver
To understand the role of transcriptional regulation in the observed alterations to metabolites,
we performed an unbiased analysis of transcriptome datasets obtained with Affymetrix Genechip
1.0 ST arrays using GeneSpring software. We found significant alterations (p (corr) < 0.05) in 3005 out
of 28,852 genes, or approximately 10% of identifiable probesets (Figure 4A,C). Of these, 601 genes were
found to have biological significance; expression levels of 449 genes were upregulated (FC > 1.5) and
152, downregulated (FC < −1.5) (Figure 4B).
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plots of biologically significant genes with differential regulation FC +/− 1.5. Red lines (B) and points 
(C) indicate significantly upregulated genes in AEM mice, whilst blue indicate significantly 
upregulated genes in FLT. Yellow indicates genes that are statistically but not biologically significant. 
Analysis of Gene Ontology (GO) biological functions (Figure 5) revealed that most upregulated 
genes were involved in metabolism or basic cellular processes, including transcription, translation, 
and DNA repair. Of note, several autophagy-related genes were altered as were genes involved in 
oxidative stress and regulation of peroxisomes, in particular fatty acid synthesis and degradation 
(Figure 5A). Our previous studies found significant alterations in both mRNA and metabolites 
associated with activation of PPAR-mediated pathways, as well as alterations in fatty acid oxidation 
in response to spaceflight [4,5]. Furthermore, as peroxisomes catalyze redox reactions and are 
potential regulators of oxidative stress-mediating signaling pathways, it is possible that peroxisomes 
and mitochondria may cooperate to determine cell fate decisions [27]. Specifically, peroxisomes 
house several enzymes that can produce or degrade ROS and reactive nitrogen species (RNS) and 
therefore may act as modulators of oxidative balance [28–30]. Recent studies have shown that 
disturbances in peroxisomal metabolism play a role in the accumulation of cellular damage due to 
oxidative stress and therefore, cellular aging. There is also evidence that peroxisomes can act as 
upstream initiators of mitochondrial ROS signaling pathways [31]. However, the precise mechanisms 
by which this occurs are yet to be fully elucidated. 
Figure 4. Hepatic gene expression is significantly altered by exposure to the space environment.
Profile (A) and scatter (C) plots of all significantly regulated genes (p (corr) < 0.05), and (B) profile
plots of biologically significant genes with differential regulation FC +/− 1.5. Red lines (B) and points
(C) indicate significantly upregulated genes in AEM mice, whilst blue indicate significantly upregulated
genes in FLT. Yellow indicates genes that are statistically but not biologically significant.
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response to spaceflight [4,5]. Furthermore, as peroxisomes catalyze redox reactions and are potential
regulators of oxidative stress-mediating signaling pathways, it is possible that peroxisomes and
mitochondria may cooperate to determine cell fate decisions [27]. Specifically, peroxisomes house
several enzymes that can produce or degrade ROS and reactive nitrogen species (RNS) and therefore
may act as modulators of oxidative balance [28–30]. Recent studies have shown that disturbances in
peroxisomal metabolism play a role in the accumulation of cellular damage due to oxidative stress
and therefore, cellular aging. There is also evidence that peroxisomes can act as upstream initiators of
mitochondrial ROS signaling pathways [31]. However, the precise mechanisms by which this occurs
are yet to be fully elucidated.Int. J. Mol. Sci. 2017, 18, 2062 8 of 22 
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and differentiation in hematopoietic stem cell lineages [32,33], as well as shifts in immune cell
phenotypes characterized by increased numbers of bone marrow-derived T cells and decreased
bone marrow-derived B cell populations [34]. Furthermore, studies using cluster of differentiation
(CD) 34+ bone marrow progenitor cells revealed decreases in total cell number in microgravity samples,
and additionally decreased erythropoiesis with concomitant increased macrophage differentiation [35].
2.4. Pathways Involved in Lipid Membrane Metabolism and Protein Biosynthesis Are Enriched in
Multi-‘Omics Datasets from Livers of Spaceflight Mice
To further validate our metabolomics results, we performed an integrated analysis of
transcriptomics and metabolomics datasets using the MetaboAnalyst Integrated Analysis function.
This algorithm performs an enrichment analysis to determine whether the observed genes and
metabolites in a given pathway appear more often than expected by random chance within the
dataset. An additional topology analysis evaluates whether a given gene or metabolite plays an
important role in a biological response based on its position within a pathway. An over-representation
analysis based on hypergeometric testing using 17,403 genes and 247 metabolites was used for the
enrichment analysis and topology was assessed with “Betweenness Centrality”, which measures the
number of shortest paths from all nodes to all others passing through a given node within the pathway.
Integrated analysis of both genes and metabolites (Figure 6A) confirmed the impact of spaceflight
on lipid membrane metabolism. Eight of the top 20 enriched pathways relate to lipid membrane
metabolism (including glycosphingolipid biosynthesis, glycerophospholipid metabolism, arachidonic acid
metabolism, inositol phosphate metabolism, glycophosphatidylinositol-anchor biosynthesis and sphingolipid
metabolism). Previously, we reported that Ingenuity Pathway Analysis revealed endocytosis as an
enriched gene pathway [4], which was also the most highly enriched pathway in the gene-centric
analysis (Figure 6B). Enrichment of inflammatory pathways was also evident by the presence of
multiple pathways related to cancer. Supporting our other metabolite set enrichment analysis, glycine,
serine and threonine metabolism had high enrichment and topology scores in the metabolite-centric
analytical workflow (Figure 6C).
Interestingly, several studies have shown that peroxisomes may alter lipid production
and concentration in response to changes in metabolism, mediating cellular signaling through
sphingolipids. In our analyses, we observed enrichment of sphingolipid biosynthesis and
sphingolipid metabolism, as well as alterations in peroxisome gene expression levels, suggesting that
spaceflight may alter peroxisome-related signaling pathways, including sphingolipids, to regulate
cellular processes [36]. Sphingolipids, specifically, are important messengers for signaling
events resulting in activation of cellular proliferation, differentiation or senescence [27,36].
Furthermore, sphingolipids have been linked to insulin resistance, oxidative stress and lipid
peroxidation in hepatocytes, suggesting a potential role of sphingolipids in the progression of
nonalcoholic fatty liver disease [37]. These results therefore indicate a potential connection between
peroxisome redox metabolism and mitochondrial oxidative stress mediated by sphingolipid signaling
pathways and resulting in upregulation of inflammatory/stress-related signaling, such as NF-κB.
Of note, aminoacyl-tRNA biosynthesis emerged as the top enriched metabolite pathway in
the metabolite-centric analysis which, when taken together with enrichment of purine metabolism
in the gene-metabolite centric analysis, suggested that spaceflight may increase biosynthesis or
even post-transcriptional modification of tRNAs, the building blocks of mRNA decoding and
protein translation. Post-transcriptional modification of tRNAs critically influences tRNA functions
such as folding, stability and decoding [38,39]. Defects in tRNA modifications and modification
enzymes are associated with oxidative stress [40] and human diseases including cancer, diabetes
and cardiomyopathy [38]. Indeed, results from a recent study in Caenorhabditis elegans associating
defects in post-transcriptional modification of mitochondrial tRNAs with dysfunctional oxidative
phosphorylation suggest that the cell's maladaptive response to hypomodified mitochondrial tRNAs
may be a mechanism underlying disease development [41]. Although speculative, the idea that
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exposure to the space environment may lead to aberrant tRNA post-transcriptional modifications is
provocative and warrants further investigation.
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Since MetaboAnalyst preferentially utilizes metabolic pathways for enrichment analyses,
we further interrogated the transcriptomic dataset using EGAN (Exploratory Gene Association
Networks) to confirm importance of enriched pathways [42]. We performed an association
analysis using all transcripts significantly changing between groups (Figure 7). Three main clusters
emerged. The first cluster focused on nucleic acid metabolism and included purine metabolism,
pyrimidine metabolism and nicotinate and nicotinamide metabolism. Purine metabolism enrichment
was dominated by strong upregulation of phosphodiesterase 4D (Pde4d, Table 3), an enzyme
with 3′,5′-cyclic-adenosine monophosphate (AMP) phosphodiesterase activity that degrades cAMP,
an important second messenger mediating signaling in multiple pathways. Adenosine monophosphate
deaminase 2 (Ampd2, Table 3), an enzyme that converts AMP to inosine monophosphate (IMP) and
maintains cellular guanine nucleotide pools [43], was downregulated, potentially attenuating protein
synthesis. This protein also mediates gluconeogenesis in the rodent liver [44] and, together with Pde4d
upregulation (Table 3), suggests pathways impacting cellular quiescence may be altered by spaceflight.
Previous studies in spaceflight have noted alterations in gene expression related to quiescence and
senescence pathways in multiple tissues. Specifically, exposure of bone marrow-derived mesenchymal
stem cells to spaceflight following addition of osteogenic differentiation factors resulted in increased
expression of genes related to neural development, neural morphogenesis and transmission of nerve
impulses and synapses in studies conducted on the International Space Station [45]. This same study
found increased expression of cell cycle arrest molecules indicating either increased differentiation of
cells in space or activation of cellular quiescence or senescence [45]. Our previous studies have also
found significant alterations in the proliferation and differentiation potential of both embryonic and
bone marrow stem cells during 13–15 days of spaceflight, with upregulation of the cell cycle arrest
and senescence marker cyclin dependent kinase inhibitor (CDKN)1a/p21 [46–49]. Notably, analysis
of our liver transcriptome dataset also found upregulation of CDKN1a/p21 (3.15 fold, p (corr) < 0.05,
Table 3), as well as upregulation of INK4C/p18 with concomitant attenuation of cyclin gene expression
(Figure S4). Similarly, GeneSet Enrichment Analysis (GSEA) using our whole transcriptome profile
showed alterations in several pathways, including quiescent cell activation, cell cycle regulation,
and activation of oxidative phosphorylation. When taken in total, these results suggest potential
systemic induction of cellular senescence due to short-term exposure to the space environment.
The second major cluster that emerged from our EGAN analysis was aminoacyl-tRNA biosynthesis,
supporting the MetaboAnalyst enrichment results, showing upregulation of expression of all genes
within the cluster. Modifications regulate the turnover of RNAs, and improperly modified tRNAs are
targeted for degradation [50], therefore it is possible that upregulation of aminoacyl-tRNA biosynthesis
actually targets cells for attenuation of protein translation due to hypomodifications or alterations of
the epitranscriptome. Finally, we observed a third cluster of genes corresponding to enrichment of
ubiquitin-mediated proteolysis. We performed Ingenuity Pathway Analysis as shown in Figure S5 and
determined that the components of the 20S proteasome were significantly upregulated, supporting the
observed pattern of molecular catabolism. Analysis of significantly upregulated datasets using GO
analysis also indicated activation of catabolism, primarily in ATP-dependent and glycolytic pathways.
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Table 3. Differentially regulated genes and biological processes in livers of FLT mice.
Gene Name Gene ID p (corr) Value Fold Change GO Biological Process
Agpat9 1-Acylglycerol-3-phosphate-O-acyltransferase 9 8.10 × 10
−4 3.740 Lipid metabolic process
Cdkn1a Cyclin-dependent kinase inhibitor1A(P21) 4.24 × 10
−4 3.153 Regulation of cyclin-dependentprotein serine
Elovl3 Elongation of very long chain fattyacids-like3 3.76 × 10
−3 3.055 Lipid metabolic process
Pnpla2 Patatin-like phospholipase domaincontaining 2 1.17 × 10
−3 2.645 Lipid metabolic process
Pde4d Phosphodiesterase 4D, cAMP specific 7.68 × 10−4 2.161 cAMP catabolic process
Pex11a Peroxisomal biogenesis factor 11 alpha 1.34 × 10−3 2.066 Peroxisome organization
Pex3 Peroxisomal biogenesis factor 3 8.82 × 10−3 2.037 Peroxisome organization
Pex19 Peroxisomal biogenesis factor 19 3.23 × 10−3 1.953 Protein targeting to peroxisome
Cirbp Cold inducible RNA binding protein 1.15 × 10−2 1.895 Response to stress
Pex16 Peroxisomal biogenesis factor 16 4.73 × 10−4 1.887 Protein targeting to peroxisome
Acot8 Acyl-Coa-thioesterase 8 4.73 × 10−4 1.776 Peroxisome organization
Atg2a Autophagy related 2A 2.59 × 10−3 1.707 Autophagy
Vwa8 Von willebrand factor A domaincontaining 8 1.94 × 10
−3 1.651 ATP catabolic process
Abcd3 ATP-binding cassette, sub-familyD(ALD), member 3 1.94 × 10
−3 1.651 ATP catabolic process
Abcg8 ATP-binding cassette, sub-family G(WHITE), member 8 2.08 × 10
−2 1.628 ATP catabolic process
Atp10d ATPase, class V, type 10D 7.48 × 10−3 1.614 ATP catabolic process
Map1lc3b Microtubule-associated protein 1 lightchain 3 β 2.50 × 10
−2 1.553 Autophagy
Abcg5 ATP binding cassette subfamily Gmember 5 4.11 × 10
−2 1.550 ATP catabolic process
Ppara peroxisome proliferator activatedreceptor α 2.10 × 10
−3 1.550 Negative regulation oftranscription
Mtor Mechanistic target of rapamycin 5.06 × 10−3 1.541 Positive regulation of proteinphosphorylation
Wipi1 WD repeat domain, phosphoinositideinteracting 1 3.81 × 10
−2 1.537 Autophagic vacuole assembly
Ppargc1b PPARG coactivator 1 β 1.24 × 10−2 1.535 Transcription frommitochondrial promoter
Atg14 Autophagy related 14 2.54 × 10−2 1.505 Autophagic vacuole assembly
Pex1 Peroxisomal biogenesis factor 1 8.32 × 10−3 1.417 Protein targeting to peroxisome
Pex11b Peroxisomal biogenesis factor 2.49 × 10−2 1.365 Peroxisome organization
Pex10 Peroxisomal biogenesis factor 10 3.85 × 10−2 1.357 Peroxisome organization
Wipi2 WD repeat domain, phosphoinositideinteracting 2 1.67 × 10
−2 1.277 Autophagic vacuole assembly
Map1lc3a Microtubule associated protein 1 lightchain 3 α 1.30 × 10
−2 1.256 Autophagic vacuole assembly
Ampd2 Adenosine monophosphate deaminase 2 1.01 × 10−2 −1.608 AMP biosynthetic process
Nfe2l2 Nuclear factor, erythroid 2 like 2 5.80 × 10−3 −1.643 Transcription, DNA-dependent
Cyp26a1 Cytochrome P450 family 26 subfamily Amember 1 4.97 × 10
−2 −2.015 Central nervous systemdevelopment
Hsp90aa1 Heat shock protein 90 α family class Amember 1 7.68 × 10
−4 −2.653 ATP catabolic process
Hspb1 Heat shock protein family B (small)member 1 1.03 × 10
−3 −5.755 Response to stress
Red indicates significantly upregulated genes in FLT compared to AEM controls, whilst blue indicates significantly
downregulated genes in FLT compared to AEM controls.
The ubiquitin–proteasome system (UPS) and autophagy are the two main intracellular
degradation pathways [51]. Autophagy primarily mediates the degradation of long-lived proteins and
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organelles, maintaining intracellular homeostasis. Since activation of the proteasome is associated
with increased autophagy, we used BIOMART [52] to obtain a list of genes associated with autophagy
GO terms and screened that list for expression changes using EGAN (Figure 8). We found significant
upregulation in expression of a number of genes, including Atg2a, important for autophagosome
formation as well as regulation of lipid droplet morphology and dispersion; microtubule-associated
genes (Map1lc3a, Map1lc3b); Wipi1 and 2, involved in pre-autophagosome formation and the autophagy
response to starvation; and Mtor, a central mediator of cellular response to stressors such as
DNA damage and oxidative stress, supporting our GSEA results (Table 3). Alterations in the
rate of autophagy have been shown to regulate ROS formation and redox balance under specific
circumstances [53]. However, proteins damaged by ROS/RNS form protein aggregates that are
degraded through the 20S proteasome in order to maintain cellular homeostasis [53]. Exposure to
chronic or sustained oxidative stress can lead to inactivation of the proteasome, resulting in
accumulation of protein conjugates. Heavily oxidized protein aggregates are also not suitable for
degradation by the proteasome [54]. These aggregates may be specific targets of autophagy-related
pathways mediated by heat shock protein chaperones, which were also altered in our analyses (Table 3).
These results suggest that spaceflight leads to upregulation of multiple autophagy-related pathways
and are consistent with activation of the proteasome and attenuation of protein synthesis in livers from
FLT mice as compared with AEM controls.Int. J. Mol. Sci. 2017, 18, 2062 14 of 22 
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Figure 8. Autophagy programs are upregulated in livers from spaceflight mice. Cluster analysis
using EGAN software was performed using genes associated with autophagy programs generated
by BIOMART. Genes were clustered using a radial force-driven display. Intensity of color
(red = upregulated, green = downregulated, grey = not detected) is associated with degree of fold
change and width of the bounding circle is inversely related to p (corr)-value. n = 6 animals per group
were used for the analysis.
Finally, we sought to determine whether decreased response to oxidative stress was associated
with induction of autophagy and we performed a pathway analysis of the nuclear factor
(erythroid-derived 2)-like 2 (NFE2L2/NRF2)-mediated response to oxidative stress (Figure 9).
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We found significant downregulation of Nrf2 expression levels in FLT mice as compared to AEM
controls (Table 3), as well as diminished expression of downstream pathway members, suggesting
that exposure to the space environment leads to attenuation of oxidative defense. Notably, spaceflight
studies using mice flown on STS-131 for 15 days also revealed downregulation of this oxidative stress
mitigator in bone marrow tissues [46,47]. Unfortunately, we did not have sufficient sample to directly
probe for changes in protein oxidation, although oxidative damage is a likely cause for the observed
increase in autophagy programs and upregulation of the proteasome in the FLT mice.
Autophagy-related programs are essential for liver regeneration [55] and repair and induction
of autophagy may occur in response to exposure to the space environment. Several studies have
characterized the molecular mechanisms involved in regeneration of the liver in response to a variety
of stress conditions and in response to partial hepatectomy (PHx), whereby a significant portion of the
rodent liver is removed and the remaining portion regenerates and restores the liver to its original
size. This process is highly regulated and includes several distinct stages, including withdrawal of
hepatocytes from quiescence, cell cycle entry and progression, cessation of cell division and return
of hepatocytes to quiescence [56–59]. Although hepatocytes are the first cells to replicate, they are
followed sequentially by other cell types within the liver including stellate cells and sinusoidal
endothelial cells [59].
A recent study demonstrated that autophagy is critical in the prevention of hepatocyte
senescence during the early stages of liver regeneration, and inhibition of autophagy-related
genes results in delayed liver regeneration, aggregation of unfolded proteins, and activation
of senescence in hepatocytes with a corresponding increase in senescence-associated secretory
phenotype (SASP)-related molecules [58]. This also coincides with considerable damage to the
mitochondria, reduced β-oxidation and reduced intrahepatic ATP generation, leading to dysregulation
of hepatocellular lipid stores [58]. As we found mild upregulation of autophagy-related genes as
well as upregulation of senescence, it is possible that autophagy pathways were initially activated to
degrade oxidized proteins. However, as chronic oxidative stress has been shown to induce hepatocyte
senescence, it is likely that senescence signaling pathways were activated in response to accumulation
of oxidized proteins and failure of autophagy mechanisms to clear these proteins. Indeed, other
studies have also demonstrated links between increased oxidative stress and increased hepatocyte
senescence, resulting in steatosis due to mitochondrial dysfunction [60–62]. This senescence-associated
mitochondrial dysfunction is a regulated process driven by signaling through p21 and through p38
mitogen-activated protein kinase (MAPK), both of which we found to be upregulated in the current
study (Table 3). Such changes are very similar to those that occur during ageing and obesity-related
pathologies, such as insulin resistance, and have been associated with impaired energy generation
and increased production of ROS. Studies conducted by us and others have shown spaceflight leads
to increased oxidative stress, increased insulin resistance, and systemic induction of aging-related
pathologies. It is possible that in the liver, increased oxidative stress and altered autophagy pathways
may cause hepatocyte senescence through activation of p21 and mitochondrial dysfunction, resulting
in hepatic steatosis (as we previously reported [5]) and impaired regenerative capacity. These molecular
changes may have important implications for the onset of obesity-related diseases and regenerative
health in the course of long-duration space exploration.
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Figure 9. NFE2L2/NRF2-mediated pathways are downregulated in spaceflight mouse livers.
Ingenuity Pathway Analysis was used for analysis of mRNA transcript levels in livers from FLT
and AEM control mice. Grey = unchanged, green = downregulated, red = upregulated. Intensity of
color correlates with degree of fold-change. n = 6/group.
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3. Materials and Methods
Animal studies were reviewed and approved by multiple Animal Care and Use Committee
(ACUC) boards, including the NASA Ames Research Center ACUC (NAS-11-002-Y1; 31 May 2011),
the NASA Kennedy Space Center (KSC) ACUC (FLT-11-078; 23 May 2011) and the University of
Colorado at Boulder Institutional ACUC (1104.11; 10 May 2011). No protocol was required for assays
performed at the University of Colorado Anschutz Medical Center or Loma Linda University since
only tissues obtained after euthanasia (no live animals) were analyzed at our sites. All NASA studies
involving vertebrate animals were carried out in strict accordance with the recommendations in the
Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.
3.1. Animals and Sample Collection
Nine-week old weight-matched female C57BL/6J mice were selected for this study because they
produce fewer odor annoyance issues and were the only gender approved for flight (n = 15/group).
Additionally, all historical data (e.g., STS-118) were obtained on female mice so the use of female
mice permitted comparisons across missions, particularly for the musculoskeletal studies that were
primary. Mice were housed in Animal Enclosure Modules (AEMs, 10 mice per AEM habitat; 5 per side
separated by a wire mesh) and either flown on the Space Shuttle Atlantis (STS-135) for 13.5 days (FLT)
or housed at the Space Life Science Laboratory (SLSL) at KSC (Ground AEM controls; AEM).
Following two days of acclimation after receipt, mice were provided a NASA NuRFB foodbar
(TD 04197; 47% carbohydrate, 17.9% protein, 3.9% lipids, 2.8% fiber, 2.80 kcal/g). All mice were
placed into AEM housing one day before flight. Environmental parameters for ground control
mice were matched as closely as possible with flight conditions using 48 h delayed telemetry data.
Conditions were controlled for temperature, humidity, and a 12/12 h light/dark cycle; foodbars and
water were provided ad libitum.
Tissues were harvested at the SLSL within 3–5 h after return of the Space Shuttle Atlantis and
were distributed amongst a team of investigations through NASA’s Biospecimen Sharing Program;
we received one half lobe of liver from six mice per group. Mice were euthanized using 4% isoflurane
followed by cardiac puncture and exsanguination. Liver lobes were extracted and dissected. A portion
of the liver was prepared in 4% paraformaldehyde and the rest snap frozen in liquid nitrogen then
shipped to either Loma Linda University or University of Colorado Anschutz Medical Campus and
stored appropriately prior to use.
3.2. Transcriptomics
Samples were prepared and analyzed as previously described [4,5]. Briefly, RNA was isolated
using an RNeasy kit (Qiagen, Germantown, MD, USA) and the Ambion WT expression kit (Thermo
Fisher Scientific, Waltham, MA, USA) was employed to prepare mRNA for whole transcriptome
microarray analysis using an Affymetrix GeneChip 1.0 ST array (Thermo Fisher Scientific). Arrays were
scanned using a GeneChip Scanner 3000 7G (Thermo Fisher Scientific) and Command Console
Software v. 3.2.3 (Thermo Fisher Scientific) to produce. CEL intensity files which were processed
with CARMAweb (Comprehensive R-based Microarray Analysis web service). GeneSpring software
(Agilent, Santa Clara, CA, USA) was used to perform statistical analysis. Specifically, samples were
first filtered on signal intensity values in order to remove background noise, statistical analysis was
performed on normalized and filtered samples using a moderated t-test with Benjamini Hochberg
FDR correction factor. Samples were then filtered based on fold change, whereby p (corr) < 0.05 and
fold change +/− 1.5 or more was considered significant. CARMAweb files were then imported into
Ingenuity Pathway Analysis (Qiagen) software for subsequent analysis.
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3.3. Metabolomics
Frozen liver pieces (n = 6/group) were shipped to Metabolon, Inc. (Morrisville, NC, USA)
and stored at −80 ◦C before use. Samples were prepared for the appropriate instrument, either
Liquid Chromatography/Mass Spectrometry (LC/MS) or Gas Chromatography/Mass Spectrometry
(GC/MS), as described previously [4,5]. Briefly, automated sample preparation was conducted
to extract metabolites for analysis by LC and GC. Extracts were placed briefly on a TurboVap®
(Zymark, Clackamas, OR, USA) to remove organic solvent. Each extract was then frozen and dried
under vacuum.
3.4. Liquid Chromatography/Mass Spectrometry (LC/MS)
Extracts were split into two aliquots, dried, then reconstituted in acidic or basic LC-compatible
solvents, each of which contained 11 or more injection standards at fixed concentrations. Metabolite
features were measured using a Waters ACQUITY UPLC (Waters, Milford, MA, USA) and a
Thermo-Finnigan LTQ-FT MS (Thermo Fisher Scientific) in two independent injections using separate
dedicated columns as described previously [4,5]. One aliquot was analyzed in positive ion mode under
acidic conditions and gradient eluted from a Waters BEH C18 2.1 mm × 100 mm column, containing
1.7 µm resin, using water and methanol as mobile phases with both containing 0.1% formic acid.
The other aliquot was analyzed in negative ion mode using basic conditions, which also employed
water/methanol, and contained 6.5 mM ammonium bicarbonate for ion pairing. Mass spectrometric
analysis alternated between MS and data-dependent MS2 scans using dynamic exclusion, scanning
from 80–1000 m/z. Accurate mass measurements were made on precursor ions with greater than
2 million counts; typical mass error was less than 5 ppm.
3.5. Gas Chromatography/Mass Spectrometry (GC/MS)
Extracts destined for GC/MS were vacuum desiccated for 24 h then derivatized under dried
nitrogen using bis(trimethylsilyl)-trifluoroacetamide (BSTFA). Volatile metabolites were separated
using 5% phenyl/95% dimethyl polysiloxane fused silica (20 m × 0.18 mm ID; 0.18 µm film thickness)
and a temperature ramp from 40 to 300 ◦C within 16 min; helium was used as the carrier gas.
Compounds were analyzed using a Thermo-Finnigan Trace DSQ fast-scanning single-quadrupole MS
(Thermo Fisher Scientific) equipped with electron impact ionization set to scan from 50–750 m/z at
unit mass resolving power, as we previously described [4,5].
3.6. Compound Identification
Mass spectral data were loaded into a relational database and peaks were identified using
Metabolon’s peak integration software [63]. Compounds were identified by comparison to library
entries of purified standards based on the combination of retention time and mass spectra.
Data were normalized to correct for variation resulting from instrument inter-day tuning differences.
Each compound was corrected by registering the medians to equal 1.00 in run-day blocks and
normalizing each data point proportionately. Missing values, assumed to be below the limit of
detection of the instrument, were imputed with the observed minimum after normalization.
3.7. Data Availability
Transcriptomics and metabolomics data are publicly accessible via the NASA GeneLAB data
base. Transcriptomics data are found at the website (Available online: https://genelab-data.ndc.nasa.
gov/genelab/accession/GLDS-25/). Metabolomics data are available at the website (Available online:
https://genelab-data.ndc.nasa.gov/genelab/accession/GLDS-108/).
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3.8. Integrated Data Analysis
MetaboAnalyst software (Available online: www.metaboanalyst.ca) was used for pathway and
enrichment analysis of metabolomics data as well as integrated analysis of transcriptomics and
metabolomics datasets. Data were log-transformed and auto-scaled then subjected to various analytical
modules within the software [64]. Ingenuity Pathway Analysis (IPA) and Exploratory Gene Association
Networks (EGAN) [42] (Available online: akt.ucsf.edu/EGAN) were used to assess pathway activation
based on changes in mRNA expression levels. Human Metabolite Database (HMDB) accession
numbers were queried and names of genes associated with metabolites exhibiting significant changes
in abundance were extracted manually. These genes were used to construct a subset list of genes that
may be functionally significant, based on metabolite abundance changes, and this subset was also
subjected to pathway and enrichment analysis.
3.9. Histology
Fixed tissue sections were processed for hematoxylin and eosin (H&E) staining as described
previously [65]. Histologic images were captured on an Olympus BX51 microscope equipped with
a 4mp Macrofire digital camera (Optronics, Tokyo, Japan) using the PictureFrame Application
2.3 (Optronics). All images were cropped and assembled using Photoshop CS2 (Adobe Systems,
Inc., San Jose, CA, USA).
3.10. Statistical Analysis
Data were analyzed with GraphPad Prism V6.0 (GraphPad Software, La Jolla, CA, USA) using
a Mann-Whitney U-test or unpaired t-test with Welch’s correction for comparison between groups.
Means ± SEM were reported. The ROUT method with Q = 1% was used to identify outliers for
exclusion from analysis. p (corr)-values less than 0.05 were selected to indicate significance.
4. Conclusions
The unbiased analyses presented here both support our previous results and extend them to show
that exposure to the space environment for only 13.5 days results in increased oxidative stress due
to elevated ROS and impaired oxidative defense (by way of attenuation of NRF2-related pathways)
in the mouse liver. Furthermore, our multi-‘omics studies suggest that accumulation of oxidized
proteins coupled with mitochondrial dysfunction may lead to activation of hepatocyte senescence,
resulting in hepatocyte lipid accumulation and steatosis. Further investigation into the potential
for liver damage in the course of long-duration space exploration is needed, as are development of
effective countermeasures to protect astronaut health.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/18/10/2062/s1.
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